Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Second Sight (EYES)

Second Sight (EYES)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Second Sight 13170 TELFAIR AVE. SYLMAR CA 91342 USA

www.secondsight.com P: 818-833-5000 F: 818-833-5067

Sector:

Medical

INDUSTRY GROUPING:

Medical Instruments

Description:

Second Sight Medical Products, Inc. is a medical device company. It develops, manufactures, and markets implantable prosthetic devices to restore some functional vision to blind patients. The Company provides Argus II system, an implantable neurostimulation device for the treatment of outer retinal degenerations, such as retinitis pigmentosa. Second Sight Medical Products, Inc. is headquartered in Sylmar, California.

Key Statistics

Overview:

Market Capitalization, $K 54,379
Enterprise Value, $K -15,211
Shares Outstanding, K 13,135
Float, K 6,935
% Float 52.80%
Short Volume Ratio 0.31
% of Insider Shareholders 47.20%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -8,920 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,080 K

Growth:

1-Year Return -63.49%
3-Year Return -79.46%
5-Year Return -84.17%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 95.31%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.06 on 03/28/22
Next Earnings Date 01/01/70
Earnings Per Share ttm -0.06
EPS Growth vs. Prev Year -26.67%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-3 on 08/19/22

EYES Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -13.58%
Return-on-Assets % -13.02%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.86
Book Value/Share 4.80
Interest Coverage 0.00
60-Month Beta 2.55
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar